Chilton Capital Management’s GSK GSK Stock Holding History

Chilton Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.44K	Hold	180	–	–	﹤0.01%	465
2026 Q1	$9.94K	Hold	180	–	–	﹤0.01%	472
2025 Q4	$8.83K	Sell	180 -67	-27%	-$3.13K	﹤0.01%	474
2025 Q3	$10.7K	Buy	247 +67	+37%	+$2.62K	﹤0.01%	482
2025 Q2	$6.91K	Hold	180	–	–	﹤0.01%	479
2025 Q1	$6.97K	Hold	180	–	–	﹤0.01%	474
2024 Q4	$6.09K	Hold	180	–	–	﹤0.01%	483
2024 Q3	$7.36K	Hold	180	–	–	﹤0.01%	502
2024 Q2	$6.93K	Hold	180	–	–	﹤0.01%	506
2024 Q1	$7.72K	Hold	180	–	–	﹤0.01%	486
2023 Q4	$6.67K	Hold	180	–	–	﹤0.01%	493
2023 Q3	$6.53K	Hold	180	–	–	﹤0.01%	449
2023 Q2	$6.42K	Sell	180 -72	-29%	-$2.58K	﹤0.01%	470
2023 Q1	$8.97K	Buy	+252	New	+$8.82K	﹤0.01%	463
2022 Q3	–	Sell	-252	Closed	-$14K	–	373
2022 Q2	$14K	Buy	+252	New	+$13.9K	﹤0.01%	430
2022 Q1	–	Sell	-358	Closed	-$20K	–	374
2021 Q4	$20K	Buy	+358	New	+$18.6K	﹤0.01%	420
2020 Q3	–	Sell	-12,423	Closed	-$777K	–	187
2020 Q2	$777K	Buy	+12,423	New	+$637K	0.07%	118
2014 Q1	–	Sell	-320	Closed	-$21.4K	–	215
2013 Q4	$21.4K	Hold	320	–	–	﹤0.01%	287
2013 Q3	$20.1K	Hold	320	–	–	﹤0.01%	293
2013 Q2	$20K	Buy	+320	New	+$20.3K	﹤0.01%	301

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Chilton Capital Management's GSK Position: Q2 2026 in Review

Chilton Capital Management held its GSK (GSK) position steady in Q2 2026 at 180 shares worth $9.44K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

Chilton Capital Management first reported a position in GSK in Q2 2013 and has held it in 20 quarters since. The position peaked at $777K in Q2 2020. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Chilton Capital Management held 180 shares of GSK worth $9.44K as of Q2 2026.
Chilton Capital Management left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Chilton Capital Management's portfolio in Q2 2026, its #465 holding.
Chilton Capital Management first reported a position in GSK in Q2 2013 and has held it in 20 quarters since.
Chilton Capital Management's GSK position peaked at $777K in Q2 2020.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.